Janine Mihm

828 total citations · 1 hit paper
13 papers, 493 citations indexed

About

Janine Mihm is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Janine Mihm has authored 13 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Janine Mihm's work include SARS-CoV-2 and COVID-19 Research (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and COVID-19 Clinical Research Studies (4 papers). Janine Mihm is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and COVID-19 Clinical Research Studies (4 papers). Janine Mihm collaborates with scholars based in Germany, Estonia and United Kingdom. Janine Mihm's co-authors include Martina Sester, Urban Sester, Tina Schmidt, Verena Klemis, David Schub, Sophie Schneitler, Sören L. Becker, Barbara C. Gärtner, Heinrike Wilkens and Franziska Hielscher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Janine Mihm

13 papers receiving 487 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

2021 216 citations Tina Schmidt, Verena Klemis et al. Nature Medicine profile →

Peers

Janine Mihm

ID

HEALT

ASZ

IMMUN

MB

Maegan L. Sheehan United States

Chompoonut Auphimai Thailand

Sam M. Murray United Kingdom

Ann-Kathrin Wallisch Germany

Lara Walotka Germany

Nils Methot United States

Regina Maruste Estonia

Joey Ming Er Lim Singapore

Gabrielle Grubbs United States

Stéphane Marot France

Maegan L. Sheehan United States

Janine Mihm

663 ×1.6

ID

100 ×1.1

HEALT

81 ×1.0

ASZ

100 ×1.2

IMMUN

154 ×2.3

MB

Citations per year, relative to Janine Mihm Janine Mihm (= 1×) peers Maegan L. Sheehan

Countries citing papers authored by Janine Mihm

Since Specialization

Citations

This map shows the geographic impact of Janine Mihm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janine Mihm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janine Mihm more than expected).

Fields of papers citing papers by Janine Mihm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janine Mihm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janine Mihm. The network helps show where Janine Mihm may publish in the future.

Co-authorship network of co-authors of Janine Mihm

This figure shows the co-authorship network connecting the top 25 collaborators of Janine Mihm. A scholar is included among the top collaborators of Janine Mihm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janine Mihm. Janine Mihm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Abu‐Omar, Amina, et al.. (2025). CMV management of patients with leukopenia after CMV high-risk kidney transplantation. Transplant Immunology. 89. 102188–102188. 1 indexed citations

2.

Mihm, Janine, Rebecca Urschel, Verena Klemis, et al.. (2024). Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients. npj Vaccines. 9(1). 25–25. 4 indexed citations

3.

Hielscher, Franziska, Tina Schmidt, Martin Enders, et al.. (2024). The inactivated herpes zoster vaccine HZ/su induces a varicella zoster virus specific cellular and humoral immune response in patients on dialysis. EBioMedicine. 108. 105335–105335. 2 indexed citations

4.

Klemis, Verena, Tina Schmidt, David Schub, et al.. (2022). Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens. Nature Communications. 13(1). 4710–4710. 30 indexed citations

5.

Schmidt, Tina, Verena Klemis, David Schub, et al.. (2021). Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination. Nature Medicine. 27(9). 1530–1535. 216 indexed citations breakdown →

6.

Schmidt, Tina, Verena Klemis, David Schub, et al.. (2021). Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients. American Journal of Transplantation. 21(12). 3990–4002. 105 indexed citations

7.

Marx, Stefanie, et al.. (2020). A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis. Frontiers in Immunology. 11. 916–916. 4 indexed citations

8.

Schub, David, Verena Klemis, Sophie Schneitler, et al.. (2020). High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19. JCI Insight. 5(20). 71 indexed citations

9.

Zeuschner, Philip, Urban Sester, Michael Stöckle, et al.. (2020). Should We Perform Old-For-Old Kidney Transplantation during the COVID-19 Pandemic? The Risk for Post-Operative Intensive Stay. Journal of Clinical Medicine. 9(6). 1835–1835. 3 indexed citations

10.

Janssen, Martin, et al.. (2017). Donor‐specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation. European Journal of Immunology. 47(7). 1220–1231. 9 indexed citations

11.

Mihm, Janine, Jan Dirks, Sigrun Smola, et al.. (2016). Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection. Journal of Clinical Virology. 82. 5–8. 5 indexed citations

12.

Wolf, M. Allison, Janine Mihm, Malinda Schaefer, et al.. (2015). Alloreactive T Cells to Identify Risk HLA Alleles for Retransplantation After Acute Accelerated Steroid-Resistant Rejection. Transplantation Proceedings. 47(8). 2425–2432. 2 indexed citations

13.

Windheim, Mark, Jennifer H. Southcombe, Elisabeth Kremmer, et al.. (2013). A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions. Proceedings of the National Academy of Sciences. 110(50). E4884–93. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact